LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $22,339,000 | -12.8% | 224,422 | 0.0% | 0.16% | -11.4% |
| Q2 2019 | $25,617,000 | -9.2% | 224,422 | 0.0% | 0.18% | -12.0% |
| Q1 2019 | $28,212,000 | -7.4% | 224,422 | 0.0% | 0.20% | -22.5% |
| Q4 2018 | $30,454,000 | -50.6% | 224,422 | 0.0% | 0.26% | -41.6% |
| Q3 2018 | $61,601,000 | +32.5% | 224,422 | 0.0% | 0.44% | +20.8% |
| Q2 2018 | $46,493,000 | +29.4% | 224,422 | 0.0% | 0.37% | +31.2% |
| Q1 2018 | $35,943,000 | +17.0% | 224,422 | 0.0% | 0.28% | -14.7% |
| Q4 2017 | $30,730,000 | – | 224,422 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |